• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

信号转导和转录激活因子3(STAT3)在慢性淋巴细胞白血病生物学中的重要作用

The Important Role of STAT3 in Chronic Lymphocytic Leukaemia Biology.

作者信息

Boudny M, Trbusek M

出版信息

Klin Onkol. 2020 Winter;33(1):32-38. doi: 10.14735/amko202032.

DOI:10.14735/amko202032
PMID:32075387
Abstract

BACKGROUND

Signal transducer and activator of transcription (STAT) proteins are cytoplasmic transcription factors that transmit the signal of cytokines, hormones and growth factors. STAT proteins control fundamental cellular processes including survival, proliferation and differentiation. Inappropriate activation of STATs might contribute to cellular transformation and leukaemogenesis. About 70% of all solid and haematological tumours exhibit aberrant STAT3 expression and/or activation, highlighting its essential role in tumourigenesis. Aberrant STAT3 activation has been found in several solid tumours and haematologic malignancies. Importantly, constitutive activation of STAT proteins has been found in several leukaemias including acute myeloid leukaemia, acute promyelocytic leukaemia, acute lymphoblastic leukaemia, chronic myeloid leukaemia and chronic lymphocytic leukaemia (CLL). Constitutively activated STAT3 plays an important role in CLL biology. CLL cells harbour constitutive phosphorylation on S727 and acetylation on K685 and transient phosphorylation on Y705 residues. Moreover, STAT3 messenger RNA expression is significantly higher in CLL cells compared to healthy B-lymphocytes. Interestingly, STAT3 inhibition was disclosed as an important by-product of ibrutinib treatment in CLL patients.

PURPOSE

The purpose of this review is to describe the consequences of STAT3 dysregulation in CLL cells. Here, we discuss aberrantly modified processes by STAT3 activation in CLL cells such as proliferation, apoptosis, B cell receptor signalling, cytokine secretion, immune checkpoint regulation, microRNA regulation, free fatty acid metabolism and electron transport chain in the mitochondria.

摘要

背景

信号转导及转录激活因子(STAT)蛋白是细胞质转录因子,可传递细胞因子、激素和生长因子的信号。STAT蛋白控制包括存活、增殖和分化在内的基本细胞过程。STAT的不适当激活可能导致细胞转化和白血病发生。约70%的实体瘤和血液肿瘤表现出异常的STAT3表达和/或激活,突出了其在肿瘤发生中的重要作用。在几种实体瘤和血液系统恶性肿瘤中发现了异常的STAT3激活。重要的是,在包括急性髓系白血病、急性早幼粒细胞白血病、急性淋巴细胞白血病、慢性髓系白血病和慢性淋巴细胞白血病(CLL)在内的几种白血病中发现了STAT蛋白的组成性激活。组成性激活的STAT3在CLL生物学中起重要作用。CLL细胞在S727位点存在组成性磷酸化,在K685位点存在乙酰化,在Y705位点存在瞬时磷酸化。此外,与健康B淋巴细胞相比,CLL细胞中STAT3信使核糖核酸的表达显著更高。有趣的是,STAT3抑制被发现是CLL患者使用伊布替尼治疗的一个重要副产物。

目的

本综述的目的是描述CLL细胞中STAT3失调的后果。在此,我们讨论CLL细胞中由STAT3激活引起的异常修饰过程,如增殖、凋亡、B细胞受体信号传导、细胞因子分泌、免疫检查点调节、微小核糖核酸调节、游离脂肪酸代谢和线粒体中的电子传递链。

相似文献

1
The Important Role of STAT3 in Chronic Lymphocytic Leukaemia Biology.信号转导和转录激活因子3(STAT3)在慢性淋巴细胞白血病生物学中的重要作用
Klin Onkol. 2020 Winter;33(1):32-38. doi: 10.14735/amko202032.
2
Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway.依鲁替尼通过 STAT3 介导的抑制调节性 B 细胞功能和抑制 PD-1/PD-L1 通路来调节 CLL 的免疫抑制微环境。
Leukemia. 2018 Apr;32(4):960-970. doi: 10.1038/leu.2017.304. Epub 2017 Oct 3.
3
B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues.慢性淋巴细胞白血病患者的B淋巴细胞含有信号转导子和转录激活子(STAT)1和STAT3,其丝氨酸残基持续磷酸化。
J Clin Invest. 1997 Dec 15;100(12):3140-8. doi: 10.1172/JCI119869.
4
STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells.STAT3 在丝氨酸 727 残基上持续磷酸化,与 DNA 结合,并在 CLL 细胞中激活转录。
Blood. 2010 Apr 8;115(14):2852-63. doi: 10.1182/blood-2009-10-230060. Epub 2010 Feb 12.
5
Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study.依鲁替尼对体内慢性淋巴细胞白血病肿瘤微环境相互作用的破坏——一项研究者发起的II期研究结果
Clin Cancer Res. 2016 Apr 1;22(7):1572-82. doi: 10.1158/1078-0432.CCR-15-1965. Epub 2015 Dec 9.
6
Pro-survival signal inhibition by CDK inhibitor dinaciclib in Chronic Lymphocytic Leukaemia.CDK抑制剂地西他滨对慢性淋巴细胞白血病的促生存信号抑制作用
Br J Haematol. 2016 Nov;175(4):641-651. doi: 10.1111/bjh.14285. Epub 2016 Jul 29.
7
STAT3 and NF-κB cooperatively control in vitro spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia.信号转导和转录激活因子3(STAT3)与核因子κB(NF-κB)共同调控慢性淋巴细胞白血病患者的体外自发凋亡及化疗反应不佳。
Oncotarget. 2016 May 31;7(22):32031-45. doi: 10.18632/oncotarget.8672.
8
Ibrutinib induces rapid down-regulation of inflammatory markers and altered transcription of chronic lymphocytic leukaemia-related genes in blood and lymph nodes.伊布替尼诱导血液和淋巴结中炎症标志物的快速下调和慢性淋巴细胞白血病相关基因转录的改变。
Br J Haematol. 2018 Oct;183(2):212-224. doi: 10.1111/bjh.15516. Epub 2018 Aug 20.
9
The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6.信号转导与转录激活因子3(STAT3)抑制剂WP1066可逆转慢性淋巴细胞白血病细胞对白介素-6诱导的组蛋白去乙酰化酶抑制剂的耐药性。
Cancer Lett. 2015 Apr 10;359(2):250-8. doi: 10.1016/j.canlet.2015.01.021. Epub 2015 Jan 27.
10
[Targeted treatment of chronic lymphocytic leukaemia].[慢性淋巴细胞白血病的靶向治疗]
Ugeskr Laeger. 2014 Apr 7;176(15).

引用本文的文献

1
ZFAS1/STAT3 axis modulates imatinib resistance of chronic myeloid leukemia cells through glucose metabolism reprogramming.ZFAS1/STAT3轴通过葡萄糖代谢重编程调节慢性髓性白血病细胞对伊马替尼的耐药性。
Front Oncol. 2025 Jul 8;15:1603060. doi: 10.3389/fonc.2025.1603060. eCollection 2025.
2
Brigimadlin (BI-907828) and napabucasin (BBI608) cooperatively trigger apoptosis in chronic lymphocytic leukemia cells by simultaneous iİnhibition of MDM2 and STAT3.布里吉马德林(BI-907828)和纳帕布卡森(BBI608)通过同时抑制MDM2和STAT3协同触发慢性淋巴细胞白血病细胞凋亡。
Mol Biol Rep. 2025 Jul 17;52(1):731. doi: 10.1007/s11033-025-10834-3.
3
MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers.
微小RNA与JAK/STAT3信号传导:血液系统恶性肿瘤中一个新的有前景的治疗靶点
Genes Dis. 2021 Dec 3;9(4):849-867. doi: 10.1016/j.gendis.2021.10.009. eCollection 2022 Jul.
4
Molecular Action of Polyphenols in Leukaemia and Their Therapeutic Potential.多酚在白血病中的分子作用及其治疗潜力。
Int J Mol Sci. 2021 Mar 17;22(6):3085. doi: 10.3390/ijms22063085.
5
Activation of Interferon Signaling in Chronic Lymphocytic Leukemia Cells Contributes to Apoptosis Resistance via a JAK-Src/STAT3/Mcl-1 Signaling Pathway.慢性淋巴细胞白血病细胞中干扰素信号的激活通过JAK-Src/STAT3/Mcl-1信号通路导致抗凋亡。
Biomedicines. 2021 Feb 13;9(2):188. doi: 10.3390/biomedicines9020188.